WO1999012494A1 - Compliant intraluminal stents - Google Patents

Compliant intraluminal stents Download PDF

Info

Publication number
WO1999012494A1
WO1999012494A1 PCT/US1998/018815 US9818815W WO9912494A1 WO 1999012494 A1 WO1999012494 A1 WO 1999012494A1 US 9818815 W US9818815 W US 9818815W WO 9912494 A1 WO9912494 A1 WO 9912494A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
links
accordance
cross
legs
Prior art date
Application number
PCT/US1998/018815
Other languages
French (fr)
Other versions
WO1999012494A9 (en
Inventor
Joel L. Berry
James E. Moore, Jr.
Original Assignee
Wake Forest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University filed Critical Wake Forest University
Priority to AT98948129T priority Critical patent/ATE291393T1/en
Priority to CA002311286A priority patent/CA2311286A1/en
Priority to DE69829494T priority patent/DE69829494T2/en
Priority to AU94764/98A priority patent/AU9476498A/en
Priority to EP98948129A priority patent/EP1021140B1/en
Publication of WO1999012494A1 publication Critical patent/WO1999012494A1/en
Publication of WO1999012494A9 publication Critical patent/WO1999012494A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/825Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91566Adjacent bands being connected to each other connected trough to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates to a stent for placement within the lumen of a vessel and, more particularly, to an intraluminal stent having end configurations that improve compliance matching of relative flexibility between the stent and the vessel to minimize flow disturbance and stress concentration in the artery wall.
  • vascular stents have been widely used as solid mechanical, structural supports to maintain an open lumen following balloon angioplasty.
  • the mechanical environment in arteries plays an important role in the development and progression of cardiovascular disease.
  • the presence of a vascular stent within the lumen of a vessel alters fluid flow patterns through the vessel. Accordingly, the use of stents may significantly influence the incidence of cardiovascular disease following balloon angioplasty due to changes in the mechanical environment caused by the stent.
  • arteries are quite complex.
  • the arterial wall is subjected to internal pressurization that also induces large, circumferentially oriented stresses.
  • the flow of blood through the artery creates a frictional shearing stress in the direction of flow. All of these stresses depend heavily on the arterial geometry, and thus vary greatly throughout the cardiovascular system.
  • the presence of arterial grafts or stents provokes changes in these mechanical factors that may be important in determining the success of such grafts or stents.
  • Compliance mismatch is a mismatch in mechanical properties that results when a relatively rigid stent is inserted within a more flexible vessel. Compliance mismatch is a particular problem at the ends of the stent where the radial flexibility of the vessel abruptly changes due to the rigidity of an expanded stent.
  • One of the consequences of compliance mismatch in a vessel is local blood flow alteration.
  • the presence of the stent in the vessel produces complex flow patterns that include vortices, which may lead to platelet activation, and flow stagnation, which may be related to platelet adhesion through increased near-wall particle residence time. Accordingly, a substantial mismatch between the circumferential compliance of arterial grafts or stents and contiguous native vessels may be deleterious to vessel patency. Accordingly, it would be desirable to reduce the problems associated with compliance mismatch.
  • an expandable, intraluminal stent is provided for deployment in a body passage, such as a blood vessel, to inhibit vessel stenosis.
  • the stent in accordance with the present invention has a gradual change in radial flexibility along the longitudinal axis of the stent, in order to minimize flow disturbance and stress concentration in the artery wall, while still providing a relatively high radial strength enabling the stent to counteract elastic recoil of the vascular wall.
  • the stent in accordance with the present invention has increased radial flexibility at the outer ends to better match the flexibility or resiliency of the adjacent vessel while maintaining increased rigidity along the central portion of the stent to provide sufficient radial support to the vessel to inhibit vessel collapse or occlusion.
  • the stent is easy to deploy, may be made of metal so that it can be imaged during deployment, and demonstrates a high expansion ratio.
  • the stent does not foreshorten along the longitudinal direction following expansion.
  • a tubular stent in a specific embodiment, includes a plurality of end links disposed in a ring at each end of the stent. Each end link is generally arcuate or V-shaped having a pair of legs joined at a central fulcrum.
  • the tubular stent also includes a plurality of rigid longitudinal struts. The longitudinal struts are oriented generally parallel to one another about a central axis of the stent.
  • the legs of the end links are connected to the ends of the longitudinal struts.
  • the legs of a single end link are connected to the ends of adjacent longitudinal struts at one end of the stent.
  • At least one deformable link is circumferentially oriented around a central portion of the stent.
  • the deformable link includes a plurality of individual V- shaped cross-links connected circumferentially between adjacent longitudinal struts. The length of the legs of the V-shaped cross-links can be changed to alter the rigidity of the expanded stent.
  • the deformable cross-links enable the stent to be expanded from a first smaller diameter into a second larger diameter while providing sufficient rigidity to inhibit collapse of the vessel.
  • the cross-links may have shorter legs than the legs of the end links so that shorter moment arms are provided by the cross-links so that the cross-links become more rigid than the end links.
  • the rigid longitudinal struts prevent longitudinal shrinkage of the stent during stent expansion.
  • the longitudinal struts extend generally from one end of the stent to the other end of the stent.
  • the longitudinal struts may span only part of the overall length of the stent.
  • one longitudinal strut can extend from one end of the strut toward a central portion of strut along one side of the tubular stent while another longitudinal strut extends from the other end of the stent toward a central portion of the stent along the opposite side of the tubular stent.
  • the end links are positioned with the legs oriented in an outward longitudinal direction to form moment arms so that radial flexibility of the end portions of the stent is increased.
  • the stent permits a gradual change in radial flexibility from an end portion of the stent to the central portion of the stent to provide improved compliance matching between the stent and the vessel.
  • the length of the legs of the end links may be changed to alter the radial flexibility of the stent for better compliance matching with the vessel.
  • Fig. 1 is an enlarged perspective view of an expandable intraluminal stent shown in an expanded configuration in accordance with the present invention
  • Fig. 2 is an enlarged, side elevational view of the stent of Fig. 1 shown in its unexpanded configuration
  • Fig. 3 is a partial cut-away view of the stent of Fig. 1 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes;
  • Fig. 4 is an enlarged, side elevational view of a stent in accordance with a second embodiment of the present invention shown in its unexpanded configuration;
  • Fig. 5 is a partial cut-away view of the stent of Fig. 4 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes;
  • Fig. 6 is an enlarged, side elevational view of a stent in accordance with a third embodiment of the present invention shown in its unexpanded configuration;
  • Fig. 7 is a partial cut-away view of the stent of Fig. 6 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes;
  • Fig. 8 is an enlarged perspective view of a stent in accordance with a fourth embodiment of the present invention shown in an expanded configuration; and Fig. 9 is a partial cut-away view of the stent of Fig. 8 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes.
  • an intraluminal stent 10 is depicted in the form of a generally tubular meshlike configuration providing a central lumen along its central longitudinal axis.
  • the generally tubular stent 10 includes a series of arcuate or V-shaped semi-rigid end links 11 which are disposed in a generally similar arrangement at each end, 18 and 19, of the tubular stent 10.
  • the end links 11 of the stent 10 are generally equally spaced around the circular periphery at each end, 18 and 19, of the stent 10 with a first end 21 of each link 11 being joined at an end of a longitudinal rigid strut 28 adjacent a second end 22 of an adjacent link 11.
  • each end link 11 is connected to the second end 22 of the adjacent link 11 at a junction 24 formed at the end of a longitudinal strut 28.
  • the junctions 24 are configured so that the tips of the junctions 24 are blunted in shape and do not form a sharp point at the ends of the longitudinal struts 28.
  • the junctions are generally frustoconical or frustopyramidical in shape so that sharp tips are not formed.
  • each end link 11 at one end 18 of the stent 10 has an opposite end link 11 symmetrically positioned at the other end 19 of the stent 10.
  • the depicted embodiment comprises six end links 11 disposed at each end, 18 and 19, of the stent 10, viable stent designs having more or less than six links at each end are possible.
  • the end links 11 are plastically deformable and have a general arcuate shape with first and second legs, 21 and 22, joined at a central fulcrum 25. As shown in Fig. 1, the end links are in a generally parabolic or semi-oval shape. The shape of the links 11 is chosen so that the legs, 21 and 22, of the links 11 flex about the central fulcrum 25 thereby creating a moment arm that enables radial flexibility of the stent 10 to be greatest at the ends, 18 and 19, of the stent 10. Towards that end, as best seen in Fig. 3, the width of each link 11 is greatest at the fulcrum 25 and tapers toward the outer ends of the legs, 21 and 22.
  • Rigid longitudinal struts 28 connect each end link 11 at one end 18 of the stent 10 so that a corresponding end link 11 is connected at the other end 19 of the stent 10. As best shown in Fig. 3, junctions 24 formed between adjoining end links 11 at the first end 18 of the stent 10 are symmetrically disposed relative to junctions 24 at the second end 19 of the stent 10.
  • the longitudinal struts 28 serve as non-deformable struts to prevent the stent 10 from foreshortening along its longitudinal axis during expansion or collapse of the stent.
  • Each longitudinal strut 28 thereby serves to maintain the junctions between the end links and the longitudinal struts at opposite ends, 18 and 19, of the stent 10 in relative longitudinal position along the longitudinal axis of the tubular stent 10.
  • the longitudinal struts 28 are also sufficiently rigid to resist bowing or bending in the circumferential direction relative to the stent 10 while providing sufficient radial flexibility or resiliency to permit compliance matching with the vessel at the ends, 18 and 19, of the stent 10.
  • At least one deformable circumferential link 30 in the form of a series of plastically-deformable, wire-like cross-links 33 is provided circumferentially about a central portion 31 of the stent 10 to circumferentially interconnect the longitudinal struts 28.
  • a plurality of generally parallel circumferential rows of links 30 may be used.
  • the cross-links 33 in each circumferential link 30 permit the stent 10 to be diametrically expanded through plastic deformation of the cross-links 33. Accordingly, the stent 10 can be expanded from a first smaller diameter as shown in Fig. 2 to, or beyond, a second larger diameter as shown in Fig. 1.
  • the generally tubular, intraluminal stent 10 comprises three rows of circumferential links 30 positioned generally in parallel around a central portion of the stent.
  • Each circumferential row of links 30 comprises a plurality of deformable, V-shaped cross-links 33 connected between adjacent longitudinal struts 28.
  • the V-shaped cross-links 33 disposed along-one of the outer rows are oriented in the same direction as the V-shaped cross-links 33 along the center row whereas the V-shaped cross-links 33 on the remaining outer row are oriented in the opposite direction.
  • each V-shaped cross-link 33 on one outer row point in a longitudinal direction opposite to the V- shaped cross-links 33 in the other two rows.
  • each V-shaped cross-link 33 bends and straightens about the apex or fulcrum 34 so that the stent 10 maintains its generally tubular shape.
  • the central lumen of the stent 10 widens, but the longitudinal struts 28 inhibit longitudinal foreshortening thereby maintaining the overall length of the stent 10. Since the stent 10 is plastically deformed, there is very little recoil and the stent 10 resists being recompressed.
  • the V-shaped cross-links 33 are dimensioned with relatively short legs 35 as compared to the relatively longer legs, 21 and 22, of the parabolic end links 11.
  • the relatively long moment arm provided by the parabolic end links 11 positioned at the outer ends of the stent 10 ensure that radial flexibility is greatest at the ends, 18 and 19, of the stent 10 and progressively less flexible toward the center 31 of the stent 10.
  • the central cross-links 33 deform about a shorter moment arm and are therefore more rigid. As such, the ends, 18 and 19, of the stent 10 have the ability to move more freely with the vessel during vessel contraction and expansion, thereby minimizing flow disturbance and stress concentration in the artery wall.
  • the stent 10 may be fabricated from a single piece of continuous tube with no welds or solder points.
  • a 316L grade seamless stainless steel tube with an outer diameter of 0.2" (4.8 mm), a nominal wall thickness of 0.012" (0.3 mm), and an overall length of 1.3" (32.5 mm) may be used.
  • the stent 10 when expanded may reach an outer diameter on the order of 0.47" (12 mm).
  • Wire electrical discharge machining (EDM) can be used for removing sections of the tubing to extremely high precision without creating burrs or deformations.
  • the wire diameter for cutting can be approximately 0.010" (0.254 mm) resulting in corners that are radiused to 0.005" (0.127 mm).
  • the stent 10 can be made having a general tubular structure comprising a thin-walled lattice frame with openings in the frame. After full expansion, the stent 10 can assume a final diameter of approximately 0.47" (12.0 mm) or 2.5 times its original diameter. Alternatively, the stent 10 can be fabricated in its expanded configuration and compressed prior to deployment. Additionally, the stent 10 does not have to be fabricated from a single piece of continuous tube. For example, the longitudinal struts 28 and/or the cross-links 33 can be made separately from the end links 11 and attached using, for example, laser welding techniques.
  • Construction of the stent 10 is not limited to stainless steel.
  • the stent 10 can also be made from any material which is compatible with the human body and any bodily fluids that the stent 10 may contact.
  • the stent 10 must be made from a material that allows for expansion of the stent 10 and must be able to maintain its expanded shape while disposed within the lumen of the body passage.
  • suitable materials for construction of the stent 10 may include tantalum and titanium.
  • the stent 10 can also be fabricated from a memory metal such as nitinol, such as the stent 10 depicted in Figs. 1-3.
  • a memory metal such as nitinol
  • the stent 10 is preferably manufactured to be in its expanded configuration when the stent 10 is at body temperature and in its collapsed configuration at some lower temperature.
  • the stent 10 is constructed from a memory metal such as nitinol
  • the stent 10 responds to temperature changes by automatically expanding from a reduced diameter to a final expanded configuration within the vessel. The stent 10 is deployed at the lower temperature and is then allowed to self expand as the stent approaches body temperature.
  • the stent 10 can be expanded from the inside when deployed at the target location using a balloon-type catheter delivery system.
  • the stent 10 can be mounted on a 0.315" (8 mm) diameter balloon (1.57" (4 cm) in length) which is attached to the end of a catheter.
  • the stent 10 can then be positioned in the desired vessel using, for example, fluoroscopic guidance to insure proper placement of the stent 10.
  • the stent 10 can then be expanded by inflating the balloon uniformly.
  • a pressure of about 10 atmospheres is usually sufficient to expand the stent 10 to its desired larger diameter. However, the pressure should be adjusted to expand the stent 10 to an appropriate final diameter for the specific vessel within which the stent 10 is being deployed.
  • the stent 10 may be deployed as a "stand alone” device, the stent 10 may also be effectively used as a vascular endograft by attaching a segment of vein, preferably an autologous vein or a synthetic graft material within the central lumen of the stent 10.
  • a segment of vein preferably an autologous vein or a synthetic graft material within the central lumen of the stent 10.
  • an autologous vein segment is utilized to provide an endothelial layer as a lining for the lumen of the stent 10.
  • the stent 110 comprises V-shaped end links 111 instead of the parabolically shaped end links 11 of stent 10 shown in Figs. 1-3.
  • the V-shaped end links provide a fulcrum at the apex 125 of the V- shape.
  • Each V-shaped end link 111 of stent 110 is connected to its adjacent end links 111 at junctions 124 formed near the outer ends of the longitudinal struts 128.
  • the ends, 136 and 137, of the longitudinal struts 128 may extend beyond the junctions 124 at the ends, 118 and 119, of the stent 110.
  • the stent 110 differs from the stent 10 described in reference to Figs.
  • the stent 110 comprises only two rows of circumferential links 130 instead of three.
  • the V- shaped cross-links 133 are disposed so that the apex 134 of each V-shaped cross-link 133 points longitudinally inward from the ends of the stent with the apex 134 of each cross-link 133 in one row longitudinally opposing the apex 134 of a cross-link 133 in the other row.
  • the legs 135 of the V-shaped cross-links 133 are relatively shorter than the legs, 121 and 122, of the V-shaped end-links 111 to provide greater radial flexibility at the ends, 118 and 119, of the stent 110 for improved compliance matching with the vessel.
  • a stent 210 in accordance with the present invention is shown in Figs. 6 and 7.
  • the stent 210 is similar to the stent 110 described in reference to Figs. 4 and 5 except that the V-shaped cross-links 233 of the circumferential links 230 are disposed to point outward toward the ends, 218 and 219, of the stent 210.
  • the legs 235 of the cross-links 233 in one row connect with the longitudinal struts 228 at the same general location as the legs 235 of the opposing cross-links 233 in the other row.
  • a plurality of rhomboidal or diamond-shaped spaces 240 are formed between the opposing cross-links 233 that interconnect adjacent longitudinal struts 228.
  • the legs 235 of the cross-links 233 are much shorter than the legs, 221 and 222, of the end links 211.
  • Still another alternate embodiment of a stent 310 in accordance with the present invention is shown in Figs. 8 and 9.
  • the stent 310 is similar to the stent 10 described in reference to Figs. 1-3 except that the longitudinal struts 328 do not extend from one end 318 of the stent 310 to the other end 319 of the stent
  • the longitudinal struts 328 comprise a plurality of first bars 339 positioned at the first end 318 of the stent 310 and a plurality of second bars 340 symmetrically positioned at the second end 319 of the stent 310.
  • First and second bars, 339 and 340 each have two ends, 342 and 343.
  • One end 342 of the first bars 339, in the form of strut segments, is connected to two adjacent end links 311 at the first end 318 of the stent 310.
  • the other end 343 of the first bars 339 is connected to one of the circumferential links 330.
  • one end 342 of each second bar 340 in the form of a strut segment, is connected to two adjacent end links 311 at the second end 319 of the stent 310 and the other end 343 of each second bar 340 is connected to one of the circumferential links 330. As shown in Fig.
  • one bar 339, 340 at each respective end of the stent is longer than the other bars at the same end of the stent and is disposed to extend to the central row of the circumferential links 330 whereas the remaining bars at the first end only extend to the row of circumferential links adjacent the first end and the remaining bars at the second end only extend to the row of circumferential links adjacent the second end of the stent.
  • These longer bars are symmetrically disposed on opposite sides of the stent.
  • the longitudinal struts 328 are arranged such that only one longitudinal strut 328 extends between the center row of circumferential links 330 and the row of circumferential links 330 nearest the first end 318 of the stent 310 and only one longitudinal strut 328 extends between the center row of circumferential links 330 and the row of circumferential links 330 nearest the second end 319 of the stent 310.

Abstract

An expandable, intraluminal tubular stent (10) is provided for insertion, and expansion within the lumen of a vessel. The stent (10) includes a plurality of longitudinal struts (28). A series of arcuated or V-shaped end links (11) are connected between the ends (18, 19) of the longitudinal struts. A series of deformable cross links (30) are circumferentially connected between adjacent longitudinal struts (28) at a center portion of the longitudinal struts to permit the stent (10) to be expanded from a first smaller diameter into a second larger diameter upon insertion into the vessel.

Description

Compliant Intraluminal stents
FIELD OF THE INVENTION
The present invention relates to a stent for placement within the lumen of a vessel and, more particularly, to an intraluminal stent having end configurations that improve compliance matching of relative flexibility between the stent and the vessel to minimize flow disturbance and stress concentration in the artery wall.
BACKGROUND OF THE INVENTION Intraluminal, vascular stents have been widely used as solid mechanical, structural supports to maintain an open lumen following balloon angioplasty. However, there is a great deal of evidence that suggests that the mechanical environment in arteries plays an important role in the development and progression of cardiovascular disease. The presence of a vascular stent within the lumen of a vessel alters fluid flow patterns through the vessel. Accordingly, the use of stents may significantly influence the incidence of cardiovascular disease following balloon angioplasty due to changes in the mechanical environment caused by the stent.
From a mechanical perspective, arteries are quite complex. The arterial wall is subjected to internal pressurization that also induces large, circumferentially oriented stresses. In addition, the flow of blood through the artery creates a frictional shearing stress in the direction of flow. All of these stresses depend heavily on the arterial geometry, and thus vary greatly throughout the cardiovascular system. The presence of arterial grafts or stents provokes changes in these mechanical factors that may be important in determining the success of such grafts or stents.
Data are now emerging that implicate a mismatch in vessel compliance (i.e., the ratio of a change in vessel cross-sectional area to a change in vessel pressure) between the vascular graft or stent and the host vessel as a culprit in neointimal hyperplasia. Compliance mismatch is a mismatch in mechanical properties that results when a relatively rigid stent is inserted within a more flexible vessel. Compliance mismatch is a particular problem at the ends of the stent where the radial flexibility of the vessel abruptly changes due to the rigidity of an expanded stent. One of the consequences of compliance mismatch in a vessel is local blood flow alteration. For example, the presence of the stent in the vessel produces complex flow patterns that include vortices, which may lead to platelet activation, and flow stagnation, which may be related to platelet adhesion through increased near-wall particle residence time. Accordingly, a substantial mismatch between the circumferential compliance of arterial grafts or stents and contiguous native vessels may be deleterious to vessel patency. Accordingly, it would be desirable to reduce the problems associated with compliance mismatch.
SUMMARY OF THE INVENTION In accordance with the present invention, an expandable, intraluminal stent is provided for deployment in a body passage, such as a blood vessel, to inhibit vessel stenosis. The stent in accordance with the present invention has a gradual change in radial flexibility along the longitudinal axis of the stent, in order to minimize flow disturbance and stress concentration in the artery wall, while still providing a relatively high radial strength enabling the stent to counteract elastic recoil of the vascular wall. In this regard, the stent in accordance with the present invention has increased radial flexibility at the outer ends to better match the flexibility or resiliency of the adjacent vessel while maintaining increased rigidity along the central portion of the stent to provide sufficient radial support to the vessel to inhibit vessel collapse or occlusion. In addition, the stent is easy to deploy, may be made of metal so that it can be imaged during deployment, and demonstrates a high expansion ratio. Furthermore, because of its unique configuration, the stent does not foreshorten along the longitudinal direction following expansion.
In a specific embodiment, a tubular stent includes a plurality of end links disposed in a ring at each end of the stent. Each end link is generally arcuate or V-shaped having a pair of legs joined at a central fulcrum. The tubular stent also includes a plurality of rigid longitudinal struts. The longitudinal struts are oriented generally parallel to one another about a central axis of the stent. The legs of the end links are connected to the ends of the longitudinal struts. The legs of a single end link are connected to the ends of adjacent longitudinal struts at one end of the stent.
At least one deformable link is circumferentially oriented around a central portion of the stent. The deformable link includes a plurality of individual V- shaped cross-links connected circumferentially between adjacent longitudinal struts. The length of the legs of the V-shaped cross-links can be changed to alter the rigidity of the expanded stent. The deformable cross-links enable the stent to be expanded from a first smaller diameter into a second larger diameter while providing sufficient rigidity to inhibit collapse of the vessel. The cross-links may have shorter legs than the legs of the end links so that shorter moment arms are provided by the cross-links so that the cross-links become more rigid than the end links.
The rigid longitudinal struts prevent longitudinal shrinkage of the stent during stent expansion. Toward this end, the longitudinal struts extend generally from one end of the stent to the other end of the stent. However, for applications where longitudinal foreshortening is not a problem or when greater longitudinal flexibility or greater radial flexibility about a central portion of the stent is desired, the longitudinal struts may span only part of the overall length of the stent. In a specific embodiment, one longitudinal strut can extend from one end of the strut toward a central portion of strut along one side of the tubular stent while another longitudinal strut extends from the other end of the stent toward a central portion of the stent along the opposite side of the tubular stent.
The end links are positioned with the legs oriented in an outward longitudinal direction to form moment arms so that radial flexibility of the end portions of the stent is increased. The stent permits a gradual change in radial flexibility from an end portion of the stent to the central portion of the stent to provide improved compliance matching between the stent and the vessel. The length of the legs of the end links may be changed to alter the radial flexibility of the stent for better compliance matching with the vessel. BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing summary, as well as the following detailed description of the preferred embodiments of the present invention, will be better understood when read in conjunction with the accompanying drawings, in which:
Fig. 1 is an enlarged perspective view of an expandable intraluminal stent shown in an expanded configuration in accordance with the present invention; Fig. 2 is an enlarged, side elevational view of the stent of Fig. 1 shown in its unexpanded configuration;
Fig. 3 is a partial cut-away view of the stent of Fig. 1 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes;
Fig. 4 is an enlarged, side elevational view of a stent in accordance with a second embodiment of the present invention shown in its unexpanded configuration;
Fig. 5 is a partial cut-away view of the stent of Fig. 4 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes; Fig. 6 is an enlarged, side elevational view of a stent in accordance with a third embodiment of the present invention shown in its unexpanded configuration;
Fig. 7 is a partial cut-away view of the stent of Fig. 6 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes;
Fig. 8 is an enlarged perspective view of a stent in accordance with a fourth embodiment of the present invention shown in an expanded configuration; and Fig. 9 is a partial cut-away view of the stent of Fig. 8 shown in a flattened, expanded configuration obtained by cutting the stent along longitudinal cutting planes.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figs. 1-3, an intraluminal stent 10 is depicted in the form of a generally tubular meshlike configuration providing a central lumen along its central longitudinal axis. The generally tubular stent 10 includes a series of arcuate or V-shaped semi-rigid end links 11 which are disposed in a generally similar arrangement at each end, 18 and 19, of the tubular stent 10. The end links 11 of the stent 10 are generally equally spaced around the circular periphery at each end, 18 and 19, of the stent 10 with a first end 21 of each link 11 being joined at an end of a longitudinal rigid strut 28 adjacent a second end 22 of an adjacent link 11. Preferably, the first end 21 of each end link 11 is connected to the second end 22 of the adjacent link 11 at a junction 24 formed at the end of a longitudinal strut 28. In order to minimize the risk of puncturing the vessel, the junctions 24 are configured so that the tips of the junctions 24 are blunted in shape and do not form a sharp point at the ends of the longitudinal struts 28. As shown in Fig. 1, the junctions are generally frustoconical or frustopyramidical in shape so that sharp tips are not formed.
The links 11 at each end, 18 and 19, of the stent 10 are positioned adjacent to one another in a generally annular arrangement around the periphery of each end, 18 and 19, of the stent 10. Accordingly, each end link 11 at one end 18 of the stent 10 has an opposite end link 11 symmetrically positioned at the other end 19 of the stent 10. Although the depicted embodiment comprises six end links 11 disposed at each end, 18 and 19, of the stent 10, viable stent designs having more or less than six links at each end are possible.
The end links 11 are plastically deformable and have a general arcuate shape with first and second legs, 21 and 22, joined at a central fulcrum 25. As shown in Fig. 1, the end links are in a generally parabolic or semi-oval shape. The shape of the links 11 is chosen so that the legs, 21 and 22, of the links 11 flex about the central fulcrum 25 thereby creating a moment arm that enables radial flexibility of the stent 10 to be greatest at the ends, 18 and 19, of the stent 10. Towards that end, as best seen in Fig. 3, the width of each link 11 is greatest at the fulcrum 25 and tapers toward the outer ends of the legs, 21 and 22.
Rigid longitudinal struts 28 connect each end link 11 at one end 18 of the stent 10 so that a corresponding end link 11 is connected at the other end 19 of the stent 10. As best shown in Fig. 3, junctions 24 formed between adjoining end links 11 at the first end 18 of the stent 10 are symmetrically disposed relative to junctions 24 at the second end 19 of the stent 10. The longitudinal struts 28 serve as non-deformable struts to prevent the stent 10 from foreshortening along its longitudinal axis during expansion or collapse of the stent. Each longitudinal strut 28 thereby serves to maintain the junctions between the end links and the longitudinal struts at opposite ends, 18 and 19, of the stent 10 in relative longitudinal position along the longitudinal axis of the tubular stent 10. The longitudinal struts 28 are also sufficiently rigid to resist bowing or bending in the circumferential direction relative to the stent 10 while providing sufficient radial flexibility or resiliency to permit compliance matching with the vessel at the ends, 18 and 19, of the stent 10.
At least one deformable circumferential link 30 in the form of a series of plastically-deformable, wire-like cross-links 33 is provided circumferentially about a central portion 31 of the stent 10 to circumferentially interconnect the longitudinal struts 28. A plurality of generally parallel circumferential rows of links 30 may be used. The cross-links 33 in each circumferential link 30 permit the stent 10 to be diametrically expanded through plastic deformation of the cross-links 33. Accordingly, the stent 10 can be expanded from a first smaller diameter as shown in Fig. 2 to, or beyond, a second larger diameter as shown in Fig. 1.
As shown in Figs. 1-3, the generally tubular, intraluminal stent 10 comprises three rows of circumferential links 30 positioned generally in parallel around a central portion of the stent. Each circumferential row of links 30 comprises a plurality of deformable, V-shaped cross-links 33 connected between adjacent longitudinal struts 28. As shown in Fig. 3, the V-shaped cross-links 33 disposed along-one of the outer rows are oriented in the same direction as the V-shaped cross-links 33 along the center row whereas the V-shaped cross-links 33 on the remaining outer row are oriented in the opposite direction. As such, the V-shaped cross-links 33 on one outer row point in a longitudinal direction opposite to the V- shaped cross-links 33 in the other two rows. As the stent 10 is diametrically expanded, each V-shaped cross-link 33 bends and straightens about the apex or fulcrum 34 so that the stent 10 maintains its generally tubular shape. The central lumen of the stent 10 widens, but the longitudinal struts 28 inhibit longitudinal foreshortening thereby maintaining the overall length of the stent 10. Since the stent 10 is plastically deformed, there is very little recoil and the stent 10 resists being recompressed.
The V-shaped cross-links 33 are dimensioned with relatively short legs 35 as compared to the relatively longer legs, 21 and 22, of the parabolic end links 11. The relatively long moment arm provided by the parabolic end links 11 positioned at the outer ends of the stent 10 ensure that radial flexibility is greatest at the ends, 18 and 19, of the stent 10 and progressively less flexible toward the center 31 of the stent 10. The central cross-links 33 deform about a shorter moment arm and are therefore more rigid. As such, the ends, 18 and 19, of the stent 10 have the ability to move more freely with the vessel during vessel contraction and expansion, thereby minimizing flow disturbance and stress concentration in the artery wall.
In a particular embodiment, the stent 10 may be fabricated from a single piece of continuous tube with no welds or solder points. For example, a 316L grade seamless stainless steel tube with an outer diameter of 0.2" (4.8 mm), a nominal wall thickness of 0.012" (0.3 mm), and an overall length of 1.3" (32.5 mm) may be used. The stent 10 when expanded may reach an outer diameter on the order of 0.47" (12 mm). Wire electrical discharge machining (EDM) can be used for removing sections of the tubing to extremely high precision without creating burrs or deformations. The wire diameter for cutting can be approximately 0.010" (0.254 mm) resulting in corners that are radiused to 0.005" (0.127 mm). Using this method the stent 10 can be made having a general tubular structure comprising a thin-walled lattice frame with openings in the frame. After full expansion, the stent 10 can assume a final diameter of approximately 0.47" (12.0 mm) or 2.5 times its original diameter. Alternatively, the stent 10 can be fabricated in its expanded configuration and compressed prior to deployment. Additionally, the stent 10 does not have to be fabricated from a single piece of continuous tube. For example, the longitudinal struts 28 and/or the cross-links 33 can be made separately from the end links 11 and attached using, for example, laser welding techniques.
Construction of the stent 10 is not limited to stainless steel. The stent 10 can also be made from any material which is compatible with the human body and any bodily fluids that the stent 10 may contact. However, the stent 10 must be made from a material that allows for expansion of the stent 10 and must be able to maintain its expanded shape while disposed within the lumen of the body passage. In addition to stainless steel, suitable materials for construction of the stent 10 may include tantalum and titanium.
The stent 10 can also be fabricated from a memory metal such as nitinol, such as the stent 10 depicted in Figs. 1-3. When the stent 10 is manufactured from a memory metal material, the stent 10 is preferably manufactured to be in its expanded configuration when the stent 10 is at body temperature and in its collapsed configuration at some lower temperature. When the stent 10 is constructed from a memory metal such as nitinol, the stent 10 responds to temperature changes by automatically expanding from a reduced diameter to a final expanded configuration within the vessel. The stent 10 is deployed at the lower temperature and is then allowed to self expand as the stent approaches body temperature.
The stent 10 can be expanded from the inside when deployed at the target location using a balloon-type catheter delivery system. For example, the stent 10 can be mounted on a 0.315" (8 mm) diameter balloon (1.57" (4 cm) in length) which is attached to the end of a catheter. The stent 10 can then be positioned in the desired vessel using, for example, fluoroscopic guidance to insure proper placement of the stent 10. The stent 10 can then be expanded by inflating the balloon uniformly. A pressure of about 10 atmospheres is usually sufficient to expand the stent 10 to its desired larger diameter. However, the pressure should be adjusted to expand the stent 10 to an appropriate final diameter for the specific vessel within which the stent 10 is being deployed.
While the stent 10 may be deployed as a "stand alone" device, the stent 10 may also be effectively used as a vascular endograft by attaching a segment of vein, preferably an autologous vein or a synthetic graft material within the central lumen of the stent 10. Preferably, an autologous vein segment is utilized to provide an endothelial layer as a lining for the lumen of the stent 10.
An alternate embodiment of a stent 110 in accordance with the present invention is shown in
Figs. 4 and 5. The stent 110 comprises V-shaped end links 111 instead of the parabolically shaped end links 11 of stent 10 shown in Figs. 1-3. The V-shaped end links provide a fulcrum at the apex 125 of the V- shape. Each V-shaped end link 111 of stent 110 is connected to its adjacent end links 111 at junctions 124 formed near the outer ends of the longitudinal struts 128. The ends, 136 and 137, of the longitudinal struts 128 may extend beyond the junctions 124 at the ends, 118 and 119, of the stent 110. In addition, the stent 110 differs from the stent 10 described in reference to Figs. 1-3 in that the stent 110 comprises only two rows of circumferential links 130 instead of three. The V- shaped cross-links 133 are disposed so that the apex 134 of each V-shaped cross-link 133 points longitudinally inward from the ends of the stent with the apex 134 of each cross-link 133 in one row longitudinally opposing the apex 134 of a cross-link 133 in the other row. The legs 135 of the V-shaped cross-links 133 are relatively shorter than the legs, 121 and 122, of the V-shaped end-links 111 to provide greater radial flexibility at the ends, 118 and 119, of the stent 110 for improved compliance matching with the vessel.
Yet another alternate embodiment of a stent 210 in accordance with the present invention is shown in Figs. 6 and 7. The stent 210 is similar to the stent 110 described in reference to Figs. 4 and 5 except that the V-shaped cross-links 233 of the circumferential links 230 are disposed to point outward toward the ends, 218 and 219, of the stent 210. In addition, the legs 235 of the cross-links 233 in one row connect with the longitudinal struts 228 at the same general location as the legs 235 of the opposing cross-links 233 in the other row. As such, a plurality of rhomboidal or diamond-shaped spaces 240 are formed between the opposing cross-links 233 that interconnect adjacent longitudinal struts 228. Again, the legs 235 of the cross-links 233 are much shorter than the legs, 221 and 222, of the end links 211. Still another alternate embodiment of a stent 310 in accordance with the present invention is shown in Figs. 8 and 9. The stent 310 is similar to the stent 10 described in reference to Figs. 1-3 except that the longitudinal struts 328 do not extend from one end 318 of the stent 310 to the other end 319 of the stent
310. Instead, portions of the longitudinal struts 328 between adjacent circumferential links 330 are missing to provide the stent 310 with greater radial flexibility. In particular, as best seen in Fig. 9, the longitudinal struts 328 comprise a plurality of first bars 339 positioned at the first end 318 of the stent 310 and a plurality of second bars 340 symmetrically positioned at the second end 319 of the stent 310. First and second bars, 339 and 340, each have two ends, 342 and 343. One end 342 of the first bars 339, in the form of strut segments, is connected to two adjacent end links 311 at the first end 318 of the stent 310. The other end 343 of the first bars 339 is connected to one of the circumferential links 330. Further, one end 342 of each second bar 340, in the form of a strut segment, is connected to two adjacent end links 311 at the second end 319 of the stent 310 and the other end 343 of each second bar 340 is connected to one of the circumferential links 330. As shown in Fig. 9, one bar 339, 340 at each respective end of the stent is longer than the other bars at the same end of the stent and is disposed to extend to the central row of the circumferential links 330 whereas the remaining bars at the first end only extend to the row of circumferential links adjacent the first end and the remaining bars at the second end only extend to the row of circumferential links adjacent the second end of the stent. These longer bars are symmetrically disposed on opposite sides of the stent. Accordingly, the longitudinal struts 328 are arranged such that only one longitudinal strut 328 extends between the center row of circumferential links 330 and the row of circumferential links 330 nearest the first end 318 of the stent 310 and only one longitudinal strut 328 extends between the center row of circumferential links 330 and the row of circumferential links 330 nearest the second end 319 of the stent 310.
It will be recognized by those skilled in the art that changes or modifications may be made to the above-described embodiments without departing from the broad inventive concepts of the invention. It should therefore be understood that this invention is not limited to the particular embodiments described herein, but is intended to include all changes and modifications that are within the scope and spirit of the invention as set forth in the claims.

Claims

WHAT IS CLAIMED IS: 1. An expandable, generally tubular, intraluminal stent, having two ends and a center portion, for insertion within the lumen of a vessel, comprising: a. a plurality of rigid longitudinal struts oriented generally parallel to one another about a central axis of the tubular stent; b. a plurality of end links connected between ends of the longitudinal struts, each end link having a first and second leg joined at a fulcrum with the first leg connected with an end of one longitudinal strut and the second leg connected with an end of an adjacent longitudinal strut so that moment arms provided by the first and second legs permit flexibility of the stent to gradually decrease from the ends of the stent toward the center portion of the stent; and c. a plurality of deformable cross-links circumferentially connecting longitudinal struts at the center portion of the stent to permit the stent to expand upon deformation of the cross-links from a first smaller diameter into a second larger diameter, the deformed cross-links being more rigid than the end links to provide increased rigidity at the center portion of the expanded stent.
2. The stent in accordance with claim 1 wherein the first end of each end link is connected to the second end of an adjacent end link.
3. The stent in accordance with claim 2 wherein the first end of each end link is connected to the second end of an adjacent end link at a junction generally at the end of the stent.
4. The stent in accordance with claim 1 wherein the end links are parabolically shaped.
5. The stent in accordance with claim 4 wherein the end links have a width which is greatest at the fulcrum and tapers towards the first and second ends.
6. The stent in accordance with claim 1 wherein the cross-links include a pair of legs joined at a fulcrum.
7. The stent in accordance with claim 6 wherein the cross-links are V-shaped.
8. The stent in accordance with claim 1 wherein the end links include a pair of legs joined at a fulcrum.
9. The stent in accordance with claim 8 wherein the end links are V-shaped.
10. The stent in accordance with claim 8 wherein the end links have a width which is greatest at the fulcrum and tapers towards the ends of the legs.
11. The stent in accordance with claim 8 wherein the cross-links include a pair of legs joined at a fulcrum.
12. The stent in accordance with claim 11 wherein the cross-links are V-shaped.
13. The stent in accordance with claim 11 wherein the legs of the cross-links are shorter relative to the legs of the end links.
14. The stent in accordance with claim 1 wherein the longitudinal struts extend generally from one end of the stent to the other end of the stent to inhibit longitudinal foreshortening of the stent during expansion of the stent.
15. The stent in accordance with claim 14 wherein the cross-links circumferentially connect adjacent longitudinal struts at the center portion of the stent.
16. The stent in accordance with claim 14 wherein the first end of each end link is connected to the second end of an adjacent end link.
17. The stent in accordance with claim 16 wherein the first end of each end link is connected to the second end of an adjacent end link at a junction generally at the end of the stent.
18. The stent in accordance with claim 14 wherein the end links are parabolically shaped.
19. The stent in accordance with claim 18 wherein the end links have a width which is greatest at the fulcrum and tapers towards the first and second ends.
20. The stent in accordance with claim 14 wherein the cross-links include a pair of legs joined at a fulcrum.
21. The stent in accordance with claim 20 wherein the cross-links are V-shaped.
22. The stent in accordance with claim 14 wherein the end links include a pair of legs joined at a fulcrum.
23. The stent in accordance with claim 22 wherein the end links are V-shaped.
24. The stent in accordance with claim 22 wherein the end links have a width which is greatest at the fulcrum and tapers towards the ends of the legs.
25. The stent in accordance with claim 22 wherein the cross-links include a pair of legs joined at a fulcrum.
26. The stent in accordance with claim 25 wherein the cross-links are V-shaped.
27. The stent in accordance with claim 25 wherein the legs of the cross-links are shorter relative to the legs of the end links.
28. The stent in accordance with claim 1 wherein the cross-links are arranged to define a plurality of deformable circumferential links.
29. The stent in accordance with claim 1 wherein at least one of the longitudinal struts extends only part of the distance between the two ends of the stent.
30. The stent in accordance with claim 29 wherein at least one of the longitudinal struts extends no more than about half the distance between the two ends of the stent.
31. The stent in accordance with claim 29 wherein at least one of the longitudinal struts comprises a plurality of bars.
32. The stent in accordance with claim 31 wherein at least one longitudinal strut comprises a first bar positioned at the first end of the stent and a second bar symmetrically positioned at the second end of the stent, the first and second bars each having two ends with one end of the first bar being connected to the end links at one end of the stent, the other end of the first bar being connected to one of the circumferential links, one end of the second bar being connected to the end links at the other end of the stent, and the other end of the second bar being connected to a different circumferential link.
30. The stent in accordance with claim 29 wherein the first end of each end link is connected to the second end of an adjacent end link.
31. The stent in accordance with claim 30 wherein the first end of each end link is connected to the second end of an adjacent end link at a junction generally at the end of the stent.
32. The stent in accordance with claim 29 wherein the end links are parabolically shaped.
33. The stent in accordance with claim 32 wherein the end links have a width which is greatest at the fulcrum and tapers towards the first and second ends.
34. The stent in accordance with claim 29 wherein the cross-links include a pair of legs joined at a fulcrum.
35. The stent in accordance with claim 34 wherein the cross-links are V-shaped.
36. The stent in accordance with claim 29 wherein the end links include a pair of legs joined at a fulcrum.
37. The stent in accordance with claim 36 wherein the end links are V-shaped.
38. The stent in accordance with claim 36 wherein the end links have a width which is greatest at the fulcrum and tapers towards the ends of the legs.
39. The stent in accordance with claim 36 wherein the cross-links include a pair of legs joined at a fulcrum.
40. The stent in accordance with claim 39 wherein the cross-links are V-shaped.
41. The stent in accordance with claim 39 wherein the legs of the cross-links are shorter relative to the legs of the end links.
42. An expandable, generally tubular, intraluminal stent, having a longitudinal axis, for insertion within the lumen of a vessel, comprising: a. a rigid center portion to internally support the vessel; and b. end sections joined to the rigid center portion having changing flexibility along the longitudinal axis of the stent, the end sections having greater radial flexibility at outer ends of the stent with the radial flexibility gradually decreasing toward the center portion.
43. The stent in accordance with claim 42 wherein the radial flexibility at the outer ends of the stent is matched to the flexibility of the vessel.
44. An expandable, generally tubular, intraluminal stent, having two ends and a center portion, for insertion within the lumen of a vessel, comprising: a. a plurality of end links disposed in a ring at each end of the tubular stent, a first end of each end link being connected to a second end of an adjacent end link, each end link having a first and a second leg joined at a fulcrum so that moment arms provided by the first and second legs permit flexibility of the stent to gradually decrease from the ends of the stent toward the center portion of the stent; b. at least one rigid longitudinal strut oriented generally parallel to a central axis of the stent, the longitudinal strut extending from the ring of end links at one end of the stent to the ring of end links at the other end of the stent; and c. at least one circumferential link attached to the longitudinal strut at about the center portion of the stent to permit the stent to expand upon deformation of the circumferential link from a first smaller diameter into a second larger diameter.
PCT/US1998/018815 1997-09-11 1998-09-10 Compliant intraluminal stents WO1999012494A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AT98948129T ATE291393T1 (en) 1997-09-11 1998-09-10 COMPLIANT INTRALUMINAL STENTS
CA002311286A CA2311286A1 (en) 1997-09-11 1998-09-10 Compliant intraluminal stents
DE69829494T DE69829494T2 (en) 1997-09-11 1998-09-10 SUBSEQUENT INTRALUMINAL STENTS
AU94764/98A AU9476498A (en) 1997-09-11 1998-09-10 Compliant intraluminal stents
EP98948129A EP1021140B1 (en) 1997-09-11 1998-09-10 Compliant intraluminal stents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/927,907 1997-09-11
US08/927,907 US6206910B1 (en) 1997-09-11 1997-09-11 Compliant intraluminal stents

Publications (2)

Publication Number Publication Date
WO1999012494A1 true WO1999012494A1 (en) 1999-03-18
WO1999012494A9 WO1999012494A9 (en) 1999-05-27

Family

ID=25455438

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/018815 WO1999012494A1 (en) 1997-09-11 1998-09-10 Compliant intraluminal stents

Country Status (7)

Country Link
US (2) US6206910B1 (en)
EP (1) EP1021140B1 (en)
AT (1) ATE291393T1 (en)
AU (1) AU9476498A (en)
CA (1) CA2311286A1 (en)
DE (1) DE69829494T2 (en)
WO (1) WO1999012494A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1036550A2 (en) * 1999-03-16 2000-09-20 amg Handelsgesellschaft für angewandte Medizin- und Gesundheitstechnik mbH Stent
EP1095632A2 (en) * 1999-10-26 2001-05-02 BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin Stent having a closed cell structure

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2380683C (en) * 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US6206910B1 (en) * 1997-09-11 2001-03-27 Wake Forest University Compliant intraluminal stents
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6558415B2 (en) * 1998-03-27 2003-05-06 Intratherapeutics, Inc. Stent
DE19829701C1 (en) * 1998-07-03 2000-03-16 Heraeus Gmbh W C Radially expandable support device IV
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6409754B1 (en) * 1999-07-02 2002-06-25 Scimed Life Systems, Inc. Flexible segmented stent
US6997944B2 (en) * 2001-08-13 2006-02-14 Advanced Cardiovascular Systems, Inc. Apparatus and method for decreasing stent gap size
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
WO2003041760A2 (en) * 2001-11-09 2003-05-22 Novoste Corporation Baloon catheter with non-deployable stent
US20040111108A1 (en) * 2001-11-09 2004-06-10 Farnan Robert C. Balloon catheter with non-deployable stent
US20040111147A1 (en) * 2002-12-03 2004-06-10 Rabkin Dmitry J. Temporary, repositionable or retrievable intraluminal devices
DE60224950T2 (en) * 2001-12-03 2009-01-29 Intek Technology LLC, Wilmington MODULAR STENT COMPRISING MULTIPLE SEGMENTS AND METHOD FOR PRODUCING STENTS
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7316710B1 (en) * 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US8080026B2 (en) 2003-01-21 2011-12-20 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US20050131523A1 (en) * 2003-04-02 2005-06-16 Mehran Bashiri Detachable and retrievable stent assembly
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US8109987B2 (en) * 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7731747B2 (en) * 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7972372B2 (en) * 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US8083791B2 (en) * 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7481834B2 (en) * 2003-04-14 2009-01-27 Tryton Medical, Inc. Stent for placement at luminal os
US7758630B2 (en) * 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US20050038501A1 (en) * 2003-08-12 2005-02-17 Moore James E. Dynamic stent
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
CA2599434C (en) * 2004-03-02 2016-09-13 Peter William Walsh A vessel or sac wall treatment and a cardiac assist device
US20060122693A1 (en) * 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
US20060122686A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
US20060122692A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20060020325A1 (en) * 2004-07-26 2006-01-26 Robert Burgermeister Material for high strength, controlled recoil stent
US20060064064A1 (en) * 2004-09-17 2006-03-23 Jang G D Two-step/dual-diameter balloon angioplasty catheter for bifurcation and side-branch vascular anatomy
WO2006034436A2 (en) 2004-09-21 2006-03-30 Stout Medical Group, L.P. Expandable support device and method of use
US20080188803A1 (en) * 2005-02-03 2008-08-07 Jang G David Triple-profile balloon catheter
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US7947207B2 (en) * 2005-04-12 2011-05-24 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US7763198B2 (en) * 2005-04-12 2010-07-27 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US10076641B2 (en) 2005-05-11 2018-09-18 The Spectranetics Corporation Methods and systems for delivering substances into luminal walls
US7291166B2 (en) * 2005-05-18 2007-11-06 Advanced Cardiovascular Systems, Inc. Polymeric stent patterns
WO2007009107A2 (en) * 2005-07-14 2007-01-18 Stout Medical Group, P.L. Expandable support device and method of use
WO2007131002A2 (en) 2006-05-01 2007-11-15 Stout Medical Group, L.P. Expandable support device and method of use
WO2008008291A2 (en) * 2006-07-13 2008-01-17 Icon Medical Corp. Stent
US20080234800A1 (en) * 2007-03-20 2008-09-25 Medtronic Vascular, Inc. Stent Including a Toggle Lock
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US20100211176A1 (en) 2008-11-12 2010-08-19 Stout Medical Group, L.P. Fixation device and method
US20100204795A1 (en) 2008-11-12 2010-08-12 Stout Medical Group, L.P. Fixation device and method
US20120035702A1 (en) * 2009-04-24 2012-02-09 Keith Horvath Stent for valve replacement
US8382818B2 (en) 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
US8298279B2 (en) * 2009-09-24 2012-10-30 Medtronic Vascular, Inc. Stent including a toggle lock strut
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
US9199066B2 (en) 2010-03-12 2015-12-01 Quattro Vascular Pte Ltd. Device and method for compartmental vessel treatment
EP2380604A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved coating formulations for scoring or cutting balloon catheters
US8535380B2 (en) 2010-05-13 2013-09-17 Stout Medical Group, L.P. Fixation device and method
EP2608747A4 (en) 2010-08-24 2015-02-11 Flexmedex Llc Support device and method for use
US8632559B2 (en) 2010-09-21 2014-01-21 Angioscore, Inc. Method and system for treating valve stenosis
US9149286B1 (en) 2010-11-12 2015-10-06 Flexmedex, LLC Guidance tool and method for use
US9707108B2 (en) 2010-11-24 2017-07-18 Tryton Medical, Inc. Support for treating vascular bifurcations
WO2013028808A1 (en) 2011-08-23 2013-02-28 Flexmedex, LLC Tissue removal device and method
EP2601995B1 (en) * 2011-12-07 2022-08-17 CAR Holding B.V. An arrangement for implementing kissing balloons for simulating a bifurcated vessel, a kit, a method of manufacturing the arrangement and a catheter provided with a buffer volume.
WO2013114201A1 (en) 2012-02-01 2013-08-08 Tanhum Feld Device for compartmental dilatation of blood vessels
SG11201403915XA (en) 2012-02-08 2014-08-28 Quattro Vascular Pte Ltd Constraining structure with non-linear axial struts
US9216033B2 (en) 2012-02-08 2015-12-22 Quattro Vascular Pte Ltd. System and method for treating biological vessels
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
EP2841024B1 (en) 2012-04-26 2017-05-03 Tryton Medical, Inc. Support for treating vascular bifurcations
NZ701992A (en) 2012-05-14 2016-03-31 Bard Inc C R Uniformly expandable stent
EP2956088A2 (en) 2013-02-12 2015-12-23 OssDsign AB Mosaic implants, kits and methods for correcting bone defects
US9220597B2 (en) * 2013-02-12 2015-12-29 Ossdsign Ab Mosaic implants, kits and methods for correcting bone defects
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US9717609B2 (en) 2013-08-01 2017-08-01 Abbott Cardiovascular Systems Inc. Variable stiffness stent
US10117668B2 (en) 2013-10-08 2018-11-06 The Spectranetics Corporation Balloon catheter with non-deployable stent having improved stability
US10064745B2 (en) 2014-03-18 2018-09-04 Abbott Cardiovascular Systems Inc. Tapered scaffolds
BR112016030273A2 (en) 2014-06-24 2017-08-22 Icon Medical Corp MEDICAL DEVICE AND METHOD FOR FORMING SAID DEVICE
BR112017002863A2 (en) 2014-08-14 2018-01-30 Ossdsign Ab bone implants for correction of bone defects
US10232148B2 (en) 2014-11-17 2019-03-19 TriReme Medical, LLC Balloon catheter system and method of using same
US9579187B1 (en) 2016-02-10 2017-02-28 Stanislaw L Zukowski Radially compliant pressure indicating stent graft
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
US20180055669A1 (en) * 2016-09-01 2018-03-01 Veinovo, LLC Luminal implant for the correction of occlusions
CN117338495A (en) * 2023-08-29 2024-01-05 南京鼓楼医院 Left ventricle outflow tract bracket and conveying system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496365A (en) * 1992-07-02 1996-03-05 Sgro; Jean-Claude Autoexpandable vascular endoprosthesis
US5630829A (en) * 1994-12-09 1997-05-20 Intervascular, Inc. High hoop strength intraluminal stent
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705239A1 (en) 1984-12-05 1987-05-01 Medinvent Sa A device for implantation and a method of implantation in a vessel using such device.
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
IE73670B1 (en) 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
FR2710834B1 (en) * 1993-10-05 1995-12-22 Guerbet Sa Expandable tubular organ for intraluminal endoprosthesis, intraluminal endoprosthesis, manufacturing process.
RU2089131C1 (en) * 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices
DE4418336A1 (en) * 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
US5591230A (en) 1994-09-07 1997-01-07 Global Therapeutics, Inc. Radially expandable stent
US5549662A (en) 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US5591198A (en) 1995-04-27 1997-01-07 Medtronic, Inc. Multiple sinusoidal wave configuration stent
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
WO1998022159A2 (en) * 1996-11-07 1998-05-28 Medtronic Instent Inc. Variable flexibility stent
US6287336B1 (en) * 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
WO1997025937A1 (en) * 1996-01-18 1997-07-24 Jang G David Programmable variably flexible modular stents
NZ331269A (en) * 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5853419A (en) * 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
US6206910B1 (en) * 1997-09-11 2001-03-27 Wake Forest University Compliant intraluminal stents
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496365A (en) * 1992-07-02 1996-03-05 Sgro; Jean-Claude Autoexpandable vascular endoprosthesis
US5630829A (en) * 1994-12-09 1997-05-20 Intervascular, Inc. High hoop strength intraluminal stent
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1036550A2 (en) * 1999-03-16 2000-09-20 amg Handelsgesellschaft für angewandte Medizin- und Gesundheitstechnik mbH Stent
EP1036550A3 (en) * 1999-03-16 2000-11-15 amg Handelsgesellschaft für angewandte Medizin- und Gesundheitstechnik mbH Stent
EP1095632A2 (en) * 1999-10-26 2001-05-02 BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin Stent having a closed cell structure

Also Published As

Publication number Publication date
EP1021140A4 (en) 2001-03-21
EP1021140B1 (en) 2005-03-23
AU9476498A (en) 1999-03-29
ATE291393T1 (en) 2005-04-15
US6572649B2 (en) 2003-06-03
US6206910B1 (en) 2001-03-27
EP1021140A1 (en) 2000-07-26
DE69829494T2 (en) 2006-05-24
WO1999012494A9 (en) 1999-05-27
US20010011188A1 (en) 2001-08-02
CA2311286A1 (en) 1999-03-18
DE69829494D1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
US6206910B1 (en) Compliant intraluminal stents
US6638300B1 (en) Radially expandable non-contracting surgical stent
US5776183A (en) Expandable stent
EP1796588B1 (en) Optimized flex link for expandable stent
US8328864B2 (en) Stent having phased hoop sections
US6997944B2 (en) Apparatus and method for decreasing stent gap size
US7867272B2 (en) Stent having twist cancellation geometry
US20030074051A1 (en) Flexible stent
KR20010030765A (en) Radially expandable nickel-titanium surgical stent
US7578840B2 (en) Stent with reduced profile
JP2020528308A (en) Intravascular stent
WO1998053760A2 (en) Locking stent
JP2004329790A (en) Flexible stent which is excellent in vascular follow-up nature and lumen diameter holding nature
CA2586095C (en) Stent having twist cancellation geometry
JP2005066203A (en) Flexible stent which expands uniformly
JP2004305450A (en) Evenly expanding flexible stent with excellent blood vessel trackability
JP2004248978A (en) Uniformly-expandable flexible stent
JP2004344204A (en) Uniformly expanded flexible stent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1-14, DESCRIPTION, REPLACED BY NEW PAGES 1-14; PAGES 15-18, CLAIMS, REPLACED BY NEW PAGES 15-18; PAGES 1/7-7/7, DRAWINGS, REPLACED BY NEW PAGES 1/7-7/7; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2311286

Country of ref document: CA

Ref country code: CA

Ref document number: 2311286

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1998948129

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 1998948129

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1998948129

Country of ref document: EP